Stephen H. Moseley

Statistics

Publications

Citations

579

H-Index

Active since

1987

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Stephen H. Moseley is an author at Vertex Pharmaceuticals (United States) specializing in surgical oncology, high-dose chemotherapy, and chemotherapy.

Publications per year

1987–2001

Publications

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.

Frederick R. Eilber, A. E. Giuliano, J J Eckardt et al. · Journal of Clinical Oncology · 1987 · 531 citations

Medicine, Oncology, Surgery +16

Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants

Shreyaskumar Patel, Nicholas E. Papadopoulos, Carl Plager et al. · Cancer · 1996 · 38 citations

Medicine, Oncology, Pharmacology +17

The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice.

Carolin Decker, Angie D. Heiser, Prasoon Chaturvedi et al. · PubMed · 2001 · 10 citations

Life Sciences, Immunology, Pharmacotherapy +13

1–3 of 3